Picture of Aravive logo

ARAV — Aravive News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Aravive Inc expected to post a loss of 32 cents a share - Earnings Preview

* Aravive Inc  ARAV.OQ   ARAV.O  is expected to show a fall
in
quarterly revenue when it reports  results on May 10
(estimated). 
    * The Houston Texas-based  company is expected to report  a
61.1% decrease in revenue to $425 thousand from $1.09 million a
year ago, according to the mean estimate from 4 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Aravive Inc is for
a loss
of 32 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 8.6%
in the last three months. ​
    * Wall Street's median 12-month price target for Aravive Inc
is
$12​, above​ its last closing price of $1.60. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2022  -0.17       -0.30      -0.46     Missed  -53.3
 Sep. 30 2022  -0.64       -0.64      -0.51     Beat    20.1
 Jun. 30 2022  -0.68       -0.59      -0.61     Missed  -3​
 Mar. 31 2022  -0.54       -0.53      -0.62     Missed  -15.9
 ​​Dec.                    -0.60      -0.62     Missed  -3
 31 2021                                                
 Sep. 30 2021  -0.47       -0.46      -0.53     Missed  -14.6​
 Jun. 30 2021  -0.38       -0.38      -0.35     Beat    8.9
 Mar. 31 2021  -0.45       -0.45      -0.44     Beat    2.7
 This summary was machine generated May 8 at 17:59 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Aravive

See all news